BerandaRLF • SWX
add
RELIEF THERAPEUTICS Holding SA
Tutup sebelumnya
CHF 2,88
Rentang hari
CHF 2,79 - CHF 2,88
Rentang tahun
CHF 1,65 - CHF 7,60
Kapitalisasi pasar
40,56 jt CHF
Volume Rata-Rata
20,74 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
SWX
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CHF) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 609,00 rb | -78,18% |
Biaya operasional | 2,57 jt | -35,75% |
Laba bersih | -2,24 jt | 1,73% |
Margin laba bersih | -367,65 | -350,28% |
Penghasilan per saham | — | — |
EBITDA | -2,01 jt | -42,73% |
Tarif pajak efektif | 0,58% | — |
Neraca
Total aset
Total liabilitas
| (CHF) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 12,50 jt | — |
Total aset | 47,99 jt | — |
Total liabilitas | 15,35 jt | — |
Total ekuitas | 32,63 jt | — |
Saham yang beredar | 12,58 jt | — |
Harga terhadap nilai buku | 1,11 | — |
Tingkat pengembalian aset | -11,77% | — |
Tingkat pengembalian modal | -16,36% | — |
Arus Kas
Perubahan kas bersih
| (CHF) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -2,24 jt | 1,73% |
Kas dari operasi | -1,88 jt | -18,76% |
Kas dari investasi | 644,00 rb | 18.500,00% |
Kas dari pembiayaan | -28,50 rb | 90,75% |
Perubahan kas bersih | -1,29 jt | 32,60% |
Arus kas bebas | -284,81 rb | — |
Tentang
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG and listed on the SIX Swiss Exchange in 2016. Wikipedia
Didirikan
2013
Karyawan
28
